193 related articles for article (PubMed ID: 25120770)
1. Apigenin suppresses GLUT-1 and p-AKT expression to enhance the chemosensitivity to cisplatin of laryngeal carcinoma Hep-2 cells: an in vitro study.
Xu YY; Wu TT; Zhou SH; Bao YY; Wang QY; Fan J; Huang YP
Int J Clin Exp Pathol; 2014; 7(7):3938-47. PubMed ID: 25120770
[TBL] [Abstract][Full Text] [Related]
2. Knockdown of S100A4 chemosensitizes human laryngeal carcinoma cells in vitro through inhibition of Slug.
Liang DP; Huang TQ; Li SJ; Chen ZJ
Eur Rev Med Pharmacol Sci; 2014 Nov; 18(22):3484-90. PubMed ID: 25491625
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of GLUT-1 expression and the PI3K/Akt pathway to enhance the chemosensitivity of laryngeal carcinoma cells in vitro.
Jiang T; Zhou ML; Fan J
Onco Targets Ther; 2018; 11():7865-7872. PubMed ID: 30464533
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting GLUT-1 expression and PI3K/Akt signaling using apigenin improves the radiosensitivity of laryngeal carcinoma in vivo.
Bao YY; Zhou SH; Lu ZJ; Fan J; Huang YP
Oncol Rep; 2015 Oct; 34(4):1805-14. PubMed ID: 26238658
[TBL] [Abstract][Full Text] [Related]
5. Apigenin inhibits the GLUT-1 glucose transporter and the phosphoinositide 3-kinase/Akt pathway in human pancreatic cancer cells.
Melstrom LG; Salabat MR; Ding XZ; Milam BM; Strouch M; Pelling JC; Bentrem DJ
Pancreas; 2008 Nov; 37(4):426-31. PubMed ID: 18953257
[TBL] [Abstract][Full Text] [Related]
6. Glucose transporter-1 expression in CD133+ laryngeal carcinoma Hep-2 cells.
Chen XH; Bao YY; Zhou SH; Wang QY; Wei Y; Fan J
Mol Med Rep; 2013 Dec; 8(6):1695-700. PubMed ID: 24146103
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cell proliferation and glucose uptake in human laryngeal carcinoma cells by antisense oligonucleotides against glucose transporter-1.
Zhou SH; Fan J; Chen XM; Cheng KJ; Wang SQ
Head Neck; 2009 Dec; 31(12):1624-33. PubMed ID: 19441091
[TBL] [Abstract][Full Text] [Related]
8. Effect on the expression of MMP-2, MT-MMP in laryngeal carcinoma Hep-2 cell line by antisense glucose transporter-1.
Xu YY; Bao YY; Zhou SH; Fan J
Arch Med Res; 2012 Jul; 43(5):395-401. PubMed ID: 22835601
[TBL] [Abstract][Full Text] [Related]
9. [AMG-102 inhibits proliferation and induces apoptosis of laryngeal squamous cell carcinoma cells by regulating c-Met/PI3K/Akt pathway].
Cao F; Lyu X; Dong KF; Fan C; Zhang JJ; Chen K; Zhang Y; Ma BJ; Hou CL; Zhang CH
Zhonghua Zhong Liu Za Zhi; 2020 Feb; 42(2):99-104. PubMed ID: 32135642
[No Abstract] [Full Text] [Related]
10. Targeted inhibition of mammalian target of rapamycin (mTOR) signaling pathway inhibits proliferation and induces apoptosis of laryngeal carcinoma cells in vitro.
Li R; Wang R; Zhai R; Dong Z
Tumori; 2011; 97(6):781-6. PubMed ID: 22322846
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of autophagy-potentiated chemosensitivity to cisplatin in laryngeal cancer Hep-2 cells.
Kang R; Wang ZH; Wang BQ; Zhang CM; Gao W; Feng Y; Bai T; Zhang HL; Huang-Pu H; Wen SX
Am J Otolaryngol; 2012; 33(6):678-84. PubMed ID: 22771248
[TBL] [Abstract][Full Text] [Related]
12. Co-Inhibition of GLUT-1 Expression and the PI3K/Akt Signaling Pathway to Enhance the Radiosensitivity of Laryngeal Carcinoma Xenografts In Vivo.
Luo XM; Xu B; Zhou ML; Bao YY; Zhou SH; Fan J; Lu ZJ
PLoS One; 2015; 10(11):e0143306. PubMed ID: 26600164
[TBL] [Abstract][Full Text] [Related]
13. TIMP-3 Increases the Chemosensitivity of Laryngeal Carcinoma to Cisplatin via Facilitating Mitochondria-Dependent Apoptosis.
Shen X; Gao X; Li H; Gu Y; Wang J
Oncol Res; 2018 Dec; 27(1):73-80. PubMed ID: 29523219
[TBL] [Abstract][Full Text] [Related]
14. Effect of antisense oligodeoxynucleotides glucose transporter-1 on enhancement of radiosensitivity of laryngeal carcinoma.
Yan SX; Luo XM; Zhou SH; Bao YY; Fan J; Lu ZJ; Liao XB; Huang YP; Wu TT; Wang QY
Int J Med Sci; 2013; 10(10):1375-86. PubMed ID: 23983599
[TBL] [Abstract][Full Text] [Related]
15. Identification of microRNAs and mRNAs associated with multidrug resistance of human laryngeal cancer Hep-2 cells.
Yin W; Wang P; Wang X; Song W; Cui X; Yu H; Zhu W
Braz J Med Biol Res; 2013 Jun; 46(6):546-54. PubMed ID: 23780424
[TBL] [Abstract][Full Text] [Related]
16. [Expression of hypoxia inducible factor-1α and correlated target genes in human laryngeal carcinoma].
XU O; LI XM; WANG MX; QU YT; LU XY; SHAN CG; SUN QJ
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 47(4):330-3. PubMed ID: 22800355
[TBL] [Abstract][Full Text] [Related]
17. GLUT-1 participates in the promotion of LncRNA CASC9 in proliferation and metastasis of laryngeal carcinoma cells.
Xi J; Wang Y; Liu H
Gene; 2020 Feb; 726():144194. PubMed ID: 31669650
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HAX-1 by miR-125a reverses cisplatin resistance in laryngeal cancer stem cells.
Liu J; Tang Q; Li S; Yang X
Oncotarget; 2016 Dec; 7(52):86446-86456. PubMed ID: 27880721
[TBL] [Abstract][Full Text] [Related]
19. Apigenin down-regulates the hypoxia response genes: HIF-1α, GLUT-1, and VEGF in human pancreatic cancer cells.
Melstrom LG; Salabat MR; Ding XZ; Strouch MJ; Grippo PJ; Mirzoeva S; Pelling JC; Bentrem DJ
J Surg Res; 2011 May; 167(2):173-81. PubMed ID: 21227456
[TBL] [Abstract][Full Text] [Related]
20. Dehydrocostus lactone inhibits cell proliferation and induces apoptosis by PI3K/Akt/Bad and ERS signalling pathway in human laryngeal carcinoma.
Zhang R; Hao J; Wu Q; Guo K; Wang C; Zhang WK; Liu W; Wang Q; Yang X
J Cell Mol Med; 2020 Jun; 24(11):6028-6042. PubMed ID: 32319208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
